logo
Select company
Select metric
$ -22.4EBIT per Share
VS
Market
1
Sector
3
Industry
3
History
27
$ 17.38Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information

Ticker

LYEL

Company Name

LYELL IMMUNOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYELL IMMUNOPHARMA INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYEL - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -331.4M$ -22.4114.79M
3/31/2025$ -334.52M$ -22.67114.75M
12/31/2024$ -342.99M$ -26.23113.07M
9/30/2024$ -203.99M$ -15.92112.82M
6/30/2024$ -210.26M$ -16.47112.77M
3/31/2024$ -228.34M$ -17.96112.71M
12/31/2023$ -234.63M$ -18.7112.55M
9/30/2023$ -190.1M$ -15.13112.57M
6/30/2023$ -209.5M$ -16.75112.51M
3/31/2023$ -181.93M$ -14.58112.48M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) EBITPS stands at $ -308.45.
  • Over the past 5 years, LYELL IMMUNOPHARMA INC's average EBITPS has been $ -38.03.
  • The median EBITPS for LYELL IMMUNOPHARMA INC during this period was $ -18.97
  • LYELL IMMUNOPHARMA INC reached its highest EBITPS over the past 5 years at $ -14.58.
  • The lowest EBITPS recorded by LYELL IMMUNOPHARMA INC in the same timeframe $ -308.45

LYELL IMMUNOPHARMA INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
FDMT : 4D MOLECULAR THERAPEUTICS INC $ -3.51INMB : INMUNE BIO INC $ -2.38HYPD : HYPERION DEFI INC $ -10.73EPRX : EUPRAXIA PHARMACEUTICALS INC $ -0.81VOR : VOR BIOPHARMA INC $ -265.73TVGN : TEVOGEN BIO HOLDINGS INC $ -0.17CRGX : CARGO THERAPEUTICS INC $ -4.61CURX : CURANEX PHARMACEUTICALS INC -MNPR : MONOPAR THERAPEUTICS $ -2.47TIL : INSTIL BIO INC $ -11.64

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for LYELL IMMUNOPHARMA INC is calculated as follows: EBIT [ $ -204.47M ] / (Shares WA [ 662.9K ] * Share Factor [ 1 ])
(=) EBITPS [ $ -308.45 ]

LYEL - EBIT per Share, Last 5 years

$ -308.45

Minimum

Dec 31, 2020

$ -14.58

Maximum

Mar 31, 2023

$ -38.03

Average

$ -18.97

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.72
max$ 10.76
average$ 1.16
median$ 0.38
std$ 3.42